Suppr超能文献

[真空辅助封闭疗法治疗心脏移植术后胸骨伤口感染:初步结果]

[Vacuum assisted closure therapy for the treatment of sternal wound infections after heart transplantation: preliminary results].

作者信息

Fleck T, Moidl R, Grimm M, Wolner E, Zuckermann A

机构信息

Dept. Cardiothoracic Surgery, Medical University of Vienna, Austria, Europe.

出版信息

Zentralbl Chir. 2007 Apr;132(2):138-41. doi: 10.1055/s-2007-960650.

Abstract

Sternal wound infection after heart transplantation is a feared and potentially life threatening complication with reported incidences between 2.5 % and 3.6 %. However, optimal therapy of sternal wound infections in heart transplant recipients remains a matter of controversy, particularly the effect of immunosuppression in those patients is still unclear. We examined 5 heart transplanted patients (4 men and 1 woman with a median age of 46 +/- 21.4 years (ranging from 14 to 59 years) in terms of inflammation and treatment response during VAC therapy. Infection begin was median 18.2 days (+/- 10 days, ranging from 5 to 28 days) after transplantation. VAC therapy lasted on average 12.2 +/- 2 days, ranging from 10 to 19 days. A median of 3 changes (range from 3 to 5) were necessary until the definitive closure. We examined C-reactive protein, leucocyte count and fibrinogen 2 days pre VAC, during VAC treatment and 2 days after definitive closure. All five patients showed an increase of leucocytes at every VAC change. Furthermore, we saw an adequate reaction to the VAC in terms of granulation tissue growth and resolution of infection. Transplanted patients had an increase of leucocytes at every VAC change. Furthermore all patients showed an adequate response of VAC treatment in terms of granulation tissue in growth and infection decline. Therefore a reduction of immunosuppressive therapy is not necessary, which in turn would increase the risk of rejection.

摘要

心脏移植术后胸骨伤口感染是一种令人担忧且可能危及生命的并发症,报告的发生率在2.5%至3.6%之间。然而,心脏移植受者胸骨伤口感染的最佳治疗方法仍存在争议,特别是免疫抑制对这些患者的影响仍不清楚。我们检查了5例心脏移植患者(4例男性和1例女性,中位年龄为46±21.4岁(范围为14至59岁))在负压封闭引流(VAC)治疗期间的炎症和治疗反应。感染开始时间为移植后中位18.2天(±10天,范围为5至28天)。VAC治疗平均持续12.2±2天,范围为10至19天。在最终闭合前,平均需要进行3次(范围为3至5次)更换。我们在VAC治疗前2天、VAC治疗期间和最终闭合后2天检查了C反应蛋白、白细胞计数和纤维蛋白原。所有5例患者在每次VAC更换时白细胞均增加。此外,就肉芽组织生长和感染消退而言,我们看到对VAC有充分反应。移植患者在每次VAC更换时白细胞均增加。此外,所有患者在肉芽组织生长和感染消退方面对VAC治疗均有充分反应。因此,没有必要减少免疫抑制治疗,否则会增加排斥反应的风险。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验